Cargando…
Rapamycin inhibits lipopolysaccharide-induced neuroinflammation in vitro and in vivo
Alzheimer's disease (AD) is the most common type of progressive neurodegenerative disorder, and is responsible for the most common form of dementia in the elderly. Inflammation occurs in the brains of patients with AD, and is critical for disease progression. In the present study, the effects o...
Autores principales: | Mengke, Na-Shun, Hu, Bei, Han, Qian-Peng, Deng, Yi-Yu, Fang, Ming, Xie, Di, Li, Ang, Zeng, Hong-Ke |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355655/ https://www.ncbi.nlm.nih.gov/pubmed/27779711 http://dx.doi.org/10.3892/mmr.2016.5883 |
Ejemplares similares
-
6-O-angeloylplenolin exerts neuroprotection against lipopolysaccharide-induced neuroinflammation in vitro and in vivo
por: Zhou, Yi-le, et al.
Publicado: (2019) -
Early-Released Interleukin-10 Significantly Inhibits Lipopolysaccharide-Elicited Neuroinflammation In Vitro
por: Wang, Yubao, et al.
Publicado: (2021) -
Deferoxamine attenuates lipopolysaccharide-induced neuroinflammation and memory impairment in mice
por: Zhang, Xiao-Ying, et al.
Publicado: (2015) -
Propofol inhibits neuroinflammation and metabolic reprogramming in microglia in vitro and in vivo
por: Guan, Shuyuan, et al.
Publicado: (2023) -
Everolimus is better than rapamycin in attenuating neuroinflammation in kainic acid-induced seizures
por: Yang, Ming-Tao, et al.
Publicado: (2017)